LICENSE AGREEMENT (AP23573 in Medical Devices)License Agreement • May 8th, 2015 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
This License Agreement (this “Agreement”) is made effective as of January 26, 2005 (the “Effective Date”), by and between ARIAD Pharmaceuticals, Inc. and ARIAD Gene Therapeutics, Inc., both corporations with a principal place of business at 26 Landsdowne Street, Cambridge, MA 02139 (collectively, “ARIAD”), and MEDINOL Ltd., a company with a principal place of business at Kiryat Atidim, P.O. Box 58165, Tel Aviv, 61581, Israel (“MEDINOL”). ARIAD and MEDINOL are each hereafter referred to individually as a “Party” and together as the “Parties.”
SECOND AMENDMENT TO LEASELease • May 8th, 2015 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
This Second Amendment to Lease (“Second Amendment”) is made as of March 24, 2015, by and between ARE-MA REGION NO. 48, LLC, a Delaware limited liability company (“Landlord”), and ARIAD Pharmaceuticals, Inc., a Delaware corporation (“Tenant”).
